[Cardiac infiltration as complication of cutaneous T-lymphoblastic non-Hodgkin's lymphoma].
Opherk
J P
JP
Lotz
J
J
Galanski
M
M
D000964:Antimetabolites, Antineoplastic / Q000008:administration & dosage / Q000627:therapeutic use; D003131:Combined Modality Therapy; D006325:Heart Atria / Q000473:pathology; D006338:Heart Neoplasms / Q000473:pathology*; D006352:Heart Ventricles / Q000473:pathology; D006801:Humans; D007278:Injections, Spinal; D016410:Lymphoma, T-Cell, Cutaneous / Q000188:drug therapy / Q000401:mortality / Q000473:pathology* / Q000532:radiotherapy; D008297:Male; D008727:Methotrexate / Q000008:administration & dosage / Q000627:therapeutic use; D008875:Middle Aged; D009361:Neoplasm Invasiveness; D013902:Radiography, Thoracic; D012878:Skin Neoplasms / Q000188:drug therapy / Q000401:mortality / Q000473:pathology* / Q000532:radiotherapy; D013997:Time Factors; D014057:Tomography, X-Ray Computed; D014261:Tricuspid Valve / Q000473:pathology
D000964:Antimetabolites, Antineoplastic; D008727:Methotrexate